These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28218319)

  • 21. Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.
    Bjorge JD; Pang A; Fujita DJ
    PLoS One; 2017; 12(6):e0180578. PubMed ID: 28666009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic SiRNA Delivery: Progress and Prospects.
    Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
    Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.
    Choi YS; Lee JY; Suh JS; Kwon YM; Lee SJ; Chung JK; Lee DS; Yang VC; Chung CP; Park YJ
    Biomaterials; 2010 Feb; 31(6):1429-43. PubMed ID: 19954842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates.
    Barrett SE; Burke RS; Abrams MT; Bason C; Busuek M; Carlini E; Carr BA; Crocker LS; Fan H; Garbaccio RM; Guidry EN; Heo JH; Howell BJ; Kemp EA; Kowtoniuk RA; Latham AH; Leone AM; Lyman M; Parmar RG; Patel M; Pechenov SY; Pei T; Pudvah NT; Raab C; Riley S; Sepp-Lorenzino L; Smith S; Soli ED; Staskiewicz S; Stern M; Truong Q; Vavrek M; Waldman JH; Walsh ES; Williams JM; Young S; Colletti SL
    J Control Release; 2014 Jun; 183():124-37. PubMed ID: 24657948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression.
    Pangburn TO; Georgiou K; Bates FS; Kokkoli E
    Langmuir; 2012 Sep; 28(35):12816-30. PubMed ID: 22827285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.
    Dou S; Yao YD; Yang XZ; Sun TM; Mao CQ; Song EW; Wang J
    J Control Release; 2012 Aug; 161(3):875-83. PubMed ID: 22762887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery of CXCR4-siRNA by scFv for HER2(+) breast cancer therapy.
    Jiang K; Li J; Yin J; Ma Q; Yan B; Zhang X; Wang L; Wang L; Liu T; Zhang Y; Fan Q; Yang A; Qiu X; Ma B
    Biomaterials; 2015 Aug; 59():77-87. PubMed ID: 25956853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
    Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic siRNA for drug-resistant HER2-positive breast cancer.
    Gu S; Hu Z; Ngamcherdtrakul W; Castro DJ; Morry J; Reda MM; Gray JW; Yantasee W
    Oncotarget; 2016 Mar; 7(12):14727-41. PubMed ID: 26894975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Efficient SiRNA Delivery Mediated by Cationic Helical Polypeptides and Polypeptide-Based Nanosystems.
    Yin L; Zheng N; Cheng J
    Methods Mol Biol; 2016; 1364():37-47. PubMed ID: 26472440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis.
    Yu-Wai-Man C; Tagalakis AD; Manunta MD; Hart SL; Khaw PT
    Sci Rep; 2016 Feb; 6():21881. PubMed ID: 26905457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
    Fang B; Jiang L; Zhang M; Ren FZ
    Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides.
    Huang Y; Cheng Q; Jin X; Ji JL; Guo S; Zheng S; Wang X; Cao H; Gao S; Liang XJ; Du Q; Liang Z
    Biomater Sci; 2016 Mar; 4(3):494-510. PubMed ID: 26783563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231).
    Eivazy P; Atyabi F; Jadidi-Niaragh F; Aghebati Maleki L; Miahipour A; Abdolalizadeh J; Yousefi M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):889-896. PubMed ID: 27188536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [siRNA-mediated inhibition of ErbB2 expression and its effect on breast cancer cell growth].
    Jiang K; Yang ZH; Wang ZY; Xu XJ; Cheng L; Zhang H; Han YJ; Ye QN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):257-9. PubMed ID: 21419042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.